Biomedical Research Blog

RockStep Solutions Partners with Novartis to Develop Transformative In Vivo Software












RockStep Solutions and the Novartis in vivo study teams worked together for over year to design and develop software that is transforming how discovery workflows are conducted. The goal of the effort was to build the best in vivo software possible using “future proof” technologies and engineering practices.  The project was lead by RockStep’s co-founder and President, Julie Morrison and members of the Novartis Head of Emerging Technologies working closely with the in vivo study team scientists, managers, and technicians. Julie Morrison, is also one of the Pistoia Alliance UXLS champions.  The full article was published in Drug Discovery World.

Continue reading →

How Drug Discovery Labs Can Benefit from LIMS

How Drug Discovery Labs Can Benefit from LIMS

In today’s competitive and highly regulated drug discovery industry, operational efficiency and compliancy are crucial to business success.  This is especially true for the in vivo research phases where operational costs are high and security, compliance and safety can become significant concerns when data is poorly managed.

Continue reading “How Drug Discovery Labs Can Benefit from LIMS”

Why Animal Research is Important for Drug Development

mouse on glove

Animal research is important for drug development as it focuses on understanding the biology and genetics of living organisms. In biomedical studies, this type of analysis aims to understand disease etiology and progression. It is used to identify potential biochemical pathways that might serve as targets for drugs to cure or mitigate diseases. Without animal research, our medical science progress would not be nearly as advanced as it is today.

Continue reading “Why Animal Research is Important for Drug Development”

In Vivo vs. In Vitro Testing – What’s the Difference?

The development of new medications is a very delicate and time-consuming process. It’s essential for drug researchers to carefully examine all potential aspects and effects a drug might have before moving it to market. This is to reduce the risk of adverse side effects negatively impacting buyers. Continue reading “In Vivo vs. In Vitro Testing – What’s the Difference?”